Proteostasis impairment in protein-misfolding and -aggregation diseases
- PMID: 24946960
- DOI: 10.1016/j.tcb.2014.05.003
Proteostasis impairment in protein-misfolding and -aggregation diseases
Abstract
Cells possess an extensive network of components to safeguard proteome integrity and maintain protein homeostasis (proteostasis). When this proteostasis network (PN) declines in performance, as may be the case during aging, newly synthesized proteins are no longer able to fold efficiently and metastable proteins lose their functionally active conformations, particularly under conditions of cell stress. Apart from loss-of-function effects, a critical consequence of PN deficiency is the accumulation of cytotoxic protein aggregates, which are also associated with many age-dependent neurodegenerative diseases and other medical disorders. Here we discuss recent evidence that the chronic production of aberrantly folded and aggregated proteins in these diseases is harmful by overtaxing PN capacity, setting in motion a vicious cycle of increasing proteome imbalance that eventually leads to PN collapse and cell death.
Keywords: degradation; molecular chaperones; neurodegenerative disease; protein (mis)folding; protein aggregation; proteostasis.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
In vivo aspects of protein folding and quality control.Science. 2016 Jul 1;353(6294):aac4354. doi: 10.1126/science.aac4354. Science. 2016. PMID: 27365453 Review.
-
Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22. Biofactors. 2017. PMID: 26899445 Review.
-
Mechanisms and Functions of Spatial Protein Quality Control.Annu Rev Biochem. 2017 Jun 20;86:97-122. doi: 10.1146/annurev-biochem-060815-014616. Epub 2017 May 10. Annu Rev Biochem. 2017. PMID: 28489421 Review.
-
Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease.J Mol Biol. 2024 Jul 15;436(14):168615. doi: 10.1016/j.jmb.2024.168615. Epub 2024 May 16. J Mol Biol. 2024. PMID: 38759929 Review.
-
Protein Misfolding Diseases.Annu Rev Biochem. 2017 Jun 20;86:21-26. doi: 10.1146/annurev-biochem-061516-044518. Epub 2017 Apr 24. Annu Rev Biochem. 2017. PMID: 28441058
Cited by
-
Proteostasis and Its Role in Disease Development.Cell Biochem Biophys. 2024 Oct 18. doi: 10.1007/s12013-024-01581-6. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39422790
-
Stress-Induced Eukaryotic Translational Regulatory Mechanisms.J Clin Med Sci. 2024;8(2):1000277. Epub 2024 Jun 24. J Clin Med Sci. 2024. PMID: 39364184 Free PMC article.
-
DDI2 protease controls embryonic development and inflammation via TCF11/NRF1.iScience. 2024 Sep 5;27(10):110893. doi: 10.1016/j.isci.2024.110893. eCollection 2024 Oct 18. iScience. 2024. PMID: 39328932 Free PMC article.
-
Mitochondrial inorganic polyphosphate is required to maintain proteostasis within the organelle.Front Cell Dev Biol. 2024 Jul 10;12:1423208. doi: 10.3389/fcell.2024.1423208. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39050895 Free PMC article.
-
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein.Acta Pharm Sin B. 2024 Jun;14(6):2505-2519. doi: 10.1016/j.apsb.2024.03.009. Epub 2024 Mar 12. Acta Pharm Sin B. 2024. PMID: 38828154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources